ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007